Ayşegül ÜNER, Mutlu HAYRAN, Arzu SAĞLAM, Ece ESİN, Barış BOYRAZ

Distribution of lymphomas in Turkey: data of 4239 cases from a single institution using the WHO classification

Background/aim: Lymphoma cases diagnosed at one of the largest tertiary reference centers in Turkey were reviewed and findings werecompared to those reported from other regions of the world.Materials and methods: Lymphomas diagnosed between 2000 and 2017 in the pathology laboratory of Hacettepe University wereidentified. A total of 4239 cases were analyzed. The WHO 2008 classification was used.Results: Hodgkin lymphomas accounted for almost 20% of cases. T-cell lymphomas were much more frequent (23% of our nonHodgkin lymphoma (NHL) cases) in comparison to all other regions of the world. The reason for this difference was the high frequencyof mycosis fungoides (MF) cases. We had significantly more cases of high-grade B-cell lymphoma (43.9% of NHLs) and fewer casesof low-grade B-cell lymphoma (33.5% of NHLs) in comparison to the rates of developed regions of the world and the reverse was truewhen compared to developing parts of the world. Burkitt lymphoma frequency (4% of NHLs) was also higher than in most parts of theworld.Conclusion: Our data reveal that the frequency of MF, Burkitt lymphoma, and Hodgkin lymphoma are considerably higher, whereasfollicular lymphoma rates are considerably lower than in most other parts of the world.

PDF

___

Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol 1998; 9: 717-720.
Alkan C, Kavak P, Somel M, Gokcumen O, Ugurlu S, Saygi C, Dal E, Bugra K, Gungor T, Sahinalp SC et al. Whole genome sequencing of Turkish genomes reveals functional private alleles and impact of genetic interactions with Europe, Asia and Africa. BMC Genomics 2014; 15: 963.
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375-2390.
Laurini JA, Perry AM, Boilesen E, Diebold J, MacLennan KA, Muller-Hermelink HK, Nathwani BN, Armitage JO, Weisenburger DD. Classification of non-Hodgkin lymphoma in Central and South America: a review of 1028 cases. Blood 2012; 120: 4795-4801.
Perry AM, Diebold J, Nathwani BN, MacLennan KA, MullerHermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD. Non-Hodgkin lymphoma in the developing world: review of 4539 cases from the International Non-Hodgkin Lymphoma Classification Project. Haematologica 2016; 101: 1244-1250.
Perry AM, Diebold J, Nathwani BN, MacLennan KA, MullerHermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD. Non-Hodgkin lymphoma in the Far East: review of 730 cases from the international non-Hodgkin lymphoma classification project. Ann Hematol 2016; 95: 245-251.
Perry AM, Perner Y, Diebold J, Nathwani BN, MacLennan KA, Muller-Hermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD. Non-Hodgkin lymphoma in Southern Africa: review of 487 cases from the International NonHodgkin Lymphoma Classification Project. Br J Haematol 2016; 172: 716-723.
Perry AM, Diebold J, Nathwani BN, MacLennan KA, MullerHermelink HK, Bast M, Boilesen E, Armitage JO, Weisenburger DD. Relative frequency of non-Hodgkin lymphoma subtypes in selected centres in North Africa, the middle east and India: a review of 971 cases. Br J Haematol 2016; 172: 699-708.
Glaser SL, Clarke CA, Keegan TH, Chang ET, Weisenburger DD. Time trends in rates of Hodgkin lymphoma histologic subtypes: true incidence changes or evolving diagnostic practice? Cancer Epidemiol Biomarkers Prev 2015; 24: 1474- 1488.
van Leeuwen MT, Turner JJ, Joske DJ, Falster MO, Srasuebkul P, Meagher NS, Grulich AE, Giles GG, Vajdic CM. Lymphoid neoplasm incidence by WHO subtype in Australia 1982-2006. Int J Cancer 2014; 135: 2146-2156.
Yang QP, Zhang WY, Yu JB, Zhao S, Xu H, Wang WY, Bi CF, Zuo Z, Wang XQ, Huang J et al. Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution. Diagn Pathol 2011; 6: 77.
Monabati A, Safaei A, Noori S, Mokhtari M, Vahedi A. Subtype distribution of lymphomas in South of Iran, analysis of 1085 cases based on World Health Organization classification. Ann Hematol 2016; 95: 613-618.
Szumera-Cieckiewicz A, Galazka K, Szpor J, Rymkiewicz G, Jesionek-Kupnicka D, Gruchala A, Ziarkiewicz-Wroblewska B, Poniatowska-Broniek G, Demczuk S, Prochorec-Sobieszek M. Distribution of lymphomas in Poland according to World Health Organization classification: analysis of 11718 cases from National Histopathological Lymphoma Register project - the Polish Lymphoma Research Group study. Int J Clin Exp Pathol 2014; 7: 3280-3286.
Kilciksiz S, Pehlivan M, Yilmaz EB, Payzin B, Bener S, Baloglu A. The clinical and pathological features of patients with hematological neoplasms: a study of hospital-based cancer registry from western Turkey. J BUON 2011; 16: 505-510.
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
Barista I, Tekuzman G, Firat D, Baltali E, Kansu E, Kars A, Ozisik Y, Ruacan S, Uzunalimoglu B, Karaagaoglu E. NonHodgkin’s lymphomas in Turkey: eighteen years’ experience at the Hacettepe University. Jpn J Cancer Res 1994; 85: 1200- 1207.
Sarpel SC, Paydas S, Tuncer I, Varinli S, Koksal M, Akoglu T. Non-Hodgkin’s lymphomas in Turkey. Cancer 1988; 62: 1653- 1657.
Mertsoylu H, Muallaoglu S, Besen AA, Erdogdu S, Sezer A, Sedef AM, Kose F, Arican A, Ozyilkan O. Primary extranodal non-Hodgkin’s lymphoma: clinicopathological features, survival and treatment outcome in two cancer centers of southern Turkey. Asian Pac J Cancer Prev 2014; 15: 7207-7211.
Aschebrook-Kilfoy B, Cocco P, La Vecchia C, Chang ET, Vajdic CM, Kadin ME, Spinelli JJ, Morton LM, Kane EV, Sampson JN et al. Medical history, lifestyle, family history, and occupational risk factors for mycosis fungoides and Sezary syndrome: the InterLymph Non-Hodgkin Lymphoma Subtypes Project. J Natl Cancer Inst Monogr 2014; 2014: 98-105.
Leoncini LCE, Stein H, Harris NL, Jaffe ES, Kluin PM. Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: International Agency for Research on Cancer; 2017. pp. 330-331.
Ozkan A, Kilic SS, Kalkan A, Ozden M, Demirdag K, Ozdarendeli A. Seropositivity of Epstein-Barr virus in Eastern Anatolian Region of Turkey. Asian Pac J Allergy Immunol 2003; 21: 49-53.
Uner A, Akyurek N, Saglam A, Abdullazade S, Uzum N, Onder S, Barista I, Benekli M. The presence of Epstein-Barr virus (EBV) in diffuse large B-cell lymphomas (DLBCLs) in Turkey: special emphasis on ‘EBV-positive DLBCL of the elderly’. APMIS 2011; 119: 309-316.
Özdil A, Doğanay L, Demir M, Öz Puyan F, Bilgi S. Detection of Epstein Barr Virus in Hodgkin’s disease in Trakya Region of Turkey; by in situ hybridization. Turk J Hematol 2002; 19: 461- 464.